XRP Eyes $3 Target Following Ripple’s $50M SEC Settlement and 8% Price Surge

Ripple Labs has reached a landmark $50 million settlement with the U.S. Securities and Exchange Commission (SEC), marking the end of a prolonged legal dispute over XRP sales. This resolution has immediately catalyzed an 8% price surge for XRP, propelling it past the critical $2.17 resistance level. As of May 9, 2025, market analysts are now speculating that the token could potentially test the $3 threshold if the current bullish momentum continues. The settlement not only brings closure to a case that has long overshadowed Ripple but also injects renewed optimism into the XRP ecosystem. This development is seen as a significant milestone for Ripple and the broader cryptocurrency market, as it removes a major regulatory overhang and could pave the way for further adoption and institutional interest in XRP.

Ripple Settles $50M SEC Case as XRP Surges 8%, Eyes $3 Target

Ripple Labs has reached a $50 million settlement with the U.S. Securities and Exchange Commission, concluding a years-long legal battle over XRP sales. The resolution triggered an immediate 8% price surge for XRP, with the cryptocurrency breaking through the critical $2.17 resistance level.

Market analysts now speculate the token could test $3 if bullish momentum sustains. The settlement brings closure to a case that had clouded Ripple’s operations since 2020, when the SEC alleged the company conducted an unregistered securities offering through XRP sales.

Ripple CEO Brad Garlinghouse and Chairman Chris Larsen were named in the original complaint. The resolution removes a significant regulatory overhang for XRP, which had been delisted from several major exchanges during the legal proceedings.

Hidden Road Expands Middle East Presence with Abu Dhabi Regulatory Nod

Hidden Road, the crypto prime brokerage recently acquired by Ripple, has secured in-principle approval from Abu Dhabi’s Financial Services Regulatory Authority. The ADGM-licensed entity will offer institutional investors clearing and prime brokerage services for both traditional and digital assets upon final authorization.

"ADGM’s rigorous regulatory framework positions it as a strategic hub for institutional expansion," said James Stickland, Hidden Road’s UAE CEO. The MOVE follows Ripple’s $1.25 billion acquisition of the firm last month—one of the sector’s largest deals to date.

Florida Pharma Firm Adopts XRP for $50M Real-Time Payments Deal

Wellgistics Health, a Florida-based pharmaceutical distributor, has positioned XRP at the Core of a $50 million financing arrangement. The publicly traded company secured an equity line of credit to establish XRP-denominated reserves and blockchain payment infrastructure.

The firm will leverage Ripple’s digital asset to settle pharmacy network transactions, streamline vendor payments, and underwrite credit facilities. This strategic adoption makes Wellgistics among the first U.S. listed companies to operationalize XRP in treasury management.

Pharmaceutical supply chains stand to benefit from XRP’s sub-cent settlement costs and elimination of traditional banking delays. "We recognize distinct advantages in XRP integration," the company stated, though declined to specify potential savings estimates.

XRP in U.S. Crypto Reserve Was Not Trump’s Idea: Here’s The Truth

New reports from Politico suggest that XRP’s inclusion in former U.S. President Donald Trump’s proposed crypto reserve may not have originated from him. Sources indicate that lobbying efforts potentially influenced the decision to include XRP in the plan.

In January 2025, TRUMP signed an executive order to form a U.S. Crypto Strategic Reserve, later announcing XRP’s inclusion on March 2 via Truth Social. By March 6, another executive order established a framework for select altcoins. However, emerging claims allege that lobbyists, particularly those tied to Ripple, played a behind-the-scenes role in XRP’s addition.

The situation raises questions about whether Trump was misled regarding XRP’s merits. Political insiders point to close ties between Ripple-affiliated lobbyists and the administration as a possible factor in the decision-making process.